MicroRNAs (miRNAs) are small noncoding RNAs that interact with mRNAs and trigger either translation repression or RNA cleavage of target genes. In this study, we investigated whether miRNA was involved in down-regulation of the luteinizing hormone receptor (LHR) in rat ovaries. An miRNA microarray was used to analyze the overall miRNA expression profile of rat ovaries in association with the down-regulation of LHR mRNA. We found that 23 miRNAs were highly expressed during this period. Combining these results with data from a bioinformatics database, clustering analysis led us to focus on miR-136-3p for further analysis. In both in vivo and in vitro studies, miR-136-3p expression levels were increased at 6 h after human chorionic gonadotropin (hCG) administration, concurrent with downregulation of LHR mRNA. Moreover, transfection of cultured granulosa cells with miR-136-3p resulted in a significant decrease in LHR mRNA levels in comparison with those of cells transfected with negative control. In contrast, transfection with a miR-136-3p inhibitor increased LHR mRNA levels. Finally, cotransfection of granulosa cells with a miR-136-3p inhibitor and a reporter vector containing the 3 0 -untranslated region (UTR) of LHR mRNA and Renilla luciferase coding sequence revealed that miR-136-3p bound directly to the 3 0 -UTR of LHR mRNA. These data demonstrated that miR-136-3p participated in the down-regulation of LHR mRNA by binding directly to LHR mRNA.
INTRODUCTION
During the menstrual cycle, follicular development, ovulation, and corpus luteum formation occur in human ovaries, maintaining reproductive functions. Every cycle is supported and controlled by complicated mechanisms involving estrogen, growth factors, and circulating follicle-stimulating hormone (FSH) and luteinizing hormone (LH) [1, 2] . LH secreted from the pituitary gland must bind to the LH-human chorionic gonadotropin (hCG) receptor (LHR) to stimulate LHR activity in modulating ovarian function, including steroidogenesis and ovulation [3, 4] . Because its long N-terminal region is distinct from that of other members of the G protein-coupled receptor (GPCR) family, LHR belongs to a subfamily of the GPCR superfamily [5] . Within the ovary, LHR is undetectable in granulosa cells of preantral and small antral follicles. However, after the follicle reaches the preovulatory stage, FSH and estrogen synergistically induce LHR in granulosa cells [6] [7] [8] .
Multiple studies have demonstrated that a preovulatory LH surge in adult cycling rats or pharmacological hCG administration to induce ovulation in equine chorionic gonadotropin (eCG)-primed immature rats can cause an acute decrease in LHR mRNA levels, which are subsequently recovered with corpus luteum formation [9, 10] . Nair and Menon [11] and Wang and Menon [12] identified mevalonate kinase (Mvk) as a novel trans-factor binding to LHR mRNA and found that Mvk was involved in the down-regulation of LHR mRNA by altering its stability after a preovulatory LH surge.
MicroRNAs (miRNAs), noncoding RNAs made up of approximately 22 nucleotides, are evolutionally well conserved in diverse organisms and negatively regulate gene expression at the post-transcriptional level [13] . To regulate gene expression, miRNAs are thought to work according to two models: in the first model, miRNAs directly cleave and destroy target RNAs as small interfering RNA (siRNAs); in the second model, miRNAs pair with target RNAs through precise or nearly precise complementarity to inhibit protein synthesis. In plants, miRNAs bind to their target mRNAs with high complementarity, resulting in degradation [13, 14] . On the other hand, animal miRNAs appear to predominantly repress translation [15, 16] . The importance of miRNA expression has been implicated in numerous biological and cellular events, and several studies have revealed that miRNAs play critical roles in cell differentiation, proliferation and apoptosis, development, the immune system, metabolism, and oncogenesis [17] [18] [19] [20] [21] [22] . Given these variable functions, miRNAs are likely involved in ovarian function through post-transcriptional regulation of gene expression. In fact, Dicer, the ribonuclease III essential for the synthesis of mature functional miRNA, has been shown to be expressed in both oocytes and granulosa cells and is involved in follicular cell development [23] . Furthermore, reports have demonstrated that hCG regulates miRNA expression in the ovaries [24, 25] .
In this study, we sought to characterize the expression and characteristics of miRNAs during ovary development. To this end, we used an miRNA microarray to identify miRNAs expressed in the ovaries of eCG-primed rats following injection of an ovulatory dose of hCG. From these data, we focused on elucidating the role of miR-136-3p, one of the miRNAs potentially targeting LHR mRNA, in the regulation of LHR expression in rat primary granulosa cells. 
MATERIALS AND METHODS

Hormones and Reagents
Animals
Female 21-day-old Wistar rats (Japan SLC, Inc., Hamamatsu, Japan) were maintained according to National Institutes of Health Guidelines for the Care and Use of Laboratory Animals and the policies of Gunma University Animal Care and Use Committee. Animals were housed in a temperature-and lightcontrolled room (12L:12D cycle; lights on at 0600 h) with food and water provided ad libitum.
For the in vivo study, 21-day-old female rats received an injection of eCG (30 IU, s.c.), followed by an injection of hCG (20 IU, s.c.) 48 h later. We then euthanized the rats to remove the ovaries at 0, 3, 6, 12, 24 , and 48 h after the injection of hCG. Ovaries were immediately stored in RNAlater tissue collection solution (Applied Biosystems, Foster City, CA).
For the in vitro study, 21-day-old female rats received injections of DES (2 mg, s.c.) for 4 days, and rat ovaries were removed for use in primary granulosa cell culture, as described below.
Primary Rat Granulosa Cell Culture
Granulosa cells were obtained from DES-primed rats. Both ovaries were removed from the rats, and granulosa cells were released by puncturing the follicles with 26-gauge needles. The granulosa cells were washed and collected by brief centrifugation, and cell viability was determined by trypan blue exclusion. The granulosa cells were then cultured in DMEM/Ham nutrient mixture F-12 supplemented with 20 mg/L gentamicin sulfate, 500 lg/L amphotericin, and 1 g/L BSA on collagen-coated plates or dishes in a humidified atmosphere containing 5% CO 2 and 95% air at 378C.
MiRNA Microarray
Rat ovaries were removed from eCG-/hCG-treated rats to analyze miRNA expression on a microarray. MiRNA microarray expression profiling was performed by TaKaRa Bio Inc. (Otsu, Japan) using rat miRNA microarray 8315K (Agilent Technologies, Santa Clara, CA), which contains 350 rat miRNAs listed in the Sanger miRBase version 10.1 (http://www.mirbase.org; hosted by the Faculty of Life Sciences, University of Manchester, Manchester, U.K.). Total RNA, including miRNAs, was isolated from the eCG-/hCGtreated rat ovaries by using the FastPure RNA kit (TaKaRa) according to the manufacturer's protocol. A quality check of the total RNAs was performed by using a model 2100 Bioanalyzer (Agilent Technologies). Labeling and hybridization of total RNA samples were performed using an miRNA microarray system (Agilent Technologies). Microarray results were extracted using Feature Extraction software (Agilent Technologies), and data were analyzed by TaKaRa.
MiRNA Target Prediction
Target miRNAs that bound to rat LHR mRNA were predicted by using the miRBase database on the basis of miRNA microarray results.
MiRNA Expression Profiling of Rat Ovaries and Rat Granulosa Cells by Using TaqMan miRNA Assays
Total RNA, including miRNAs, was isolated from rat ovaries or rat granulosa cells by using the mirVana miRNA isolation kit (Ambion Inc., Austin, TX) according to the manufacturer's protocol. Concentrations of total RNA were measured using a Nanodrop-1000 spectrophotometer (Thermo Scientific, Wilmington, DE). Total RNA was then reverse transcribed with specific RT primers from a TaqMan miRNA assay kit (rno-miR-136-3p: 002100, and 4.5S RNA [H]: 001716 as an internal control; Ambion Inc.). Single-stranded cDNA was synthesized from 10 ng of total RNA in a 15-lL reaction volume with the micro-RNA reverse transcription kit (Applied Biosystems) according to the manufacturer's protocol. Reaction mixtures were incubated for 30 min at 168C, for 30 min at 308C, and for 5 min at 858C in a thermal cycler. Real-time RT-PCR was performed using sequence-specific primers from a TaqMan Micro-RNA assay kit according to the manufacturer's instructions. Reactions were carried out with an ABI Prism 7000 sequence detection system (Applied Biosystems) in a 20-ll reaction volume at 958C for 10 min, then 40 cycles at 958C for 15 sec, and at 608C for 60 sec. All reactions were tested in triplicate. We determined the threshold cycle (C t ) values for each reaction, and their mean values were used to determine the relative miR-136-3p expression levels using the DDC t method. Additionally, we calculated the percentage of rat LHR mRNA or miR-136-3p expression by using DDC t values for each reaction as follows:
These values were used to calculate the relative expression level of LHR or miR-136-3p, with normalization to the expression of hCG at 0 h in the control (Pre-miR-negative control #1), which was set at 1.
Expression of LHR mRNA Expression in Rat Ovaries or Rat Granulosa Cells by Using TaqMan Gene Expression Assays
Total RNA was isolated from rat ovaries or rat granulosa cells, and the concentrations were measured as described above. The isolated RNAs (2 lg of each sample) were treated with DNase I (Invitrogen) to eliminate residual genomic DNA. These RNAs were reverse transcribed with random primers, a 10 mM deoxynucleoside triphosphate mixture, and SuperScript III reverse transcriptase (Invitrogen) according to the manufacturer's protocol. Reaction mixtures were incubated for 5 min at 258C, 60 min at 508C, and 15 min at 708C in a thermal cycler. To remove complementary RNA, RNase H was added to the cDNAs, and the reaction mixtures were incubated for 20 min at 378C. Realtime RT-PCR was performed using TaqMan gene expression assays (luteinizing hormone/choriogonadotropin receptor: Rn00564309_m1; and eukaryotic 18S rRNA: Hs99999901_s1 as an internal control; Applied Biosystems) according to the manufacturer's instructions. Rat LHR mRNA expression levels were measured in the same way as in the miRNA assays.
MiRNA Precursor miR-136-3p and miRNA Inhibitor miR-136-3p Transfection
Primary rat granulosa cells (8.0 3 10 4 to 10 3 10 4 cells, obtained from DESprimed rats) were cultured in 24-well tissue culture plates with serum-free medium. Twenty-four hours later, the cells were incubated with FSH (30 ng/ ml) and estradiol (10 nM) for 48 h. The cells were then transfected with precursor (Pre)-miR-136-3p, inhibitor (Anti)-miR-136-3p, or Pre-miR-negative control #1 (100 nM or 200 nM each; product IDs PM12636, AM12636, and AM17110, respectively; Ambion, Inc.) using siPORT Neo-FX transfection agent according to the manufacturer's protocol. Twelve hours later, hCG (30 ng/ml) was added to the culture medium to induce down-regulation of LHR mRNA.
To evaluate the effects of Pre-miR-136-3p and Anti-miR-136-3p, we performed real-time RT-PCR using TaqMan gene expression assays at 12 and 24 h after hCG treatment to evaluate the levels of LHR mRNA and miR-136-3p expression compared to that of the Pre-miR-negative control #1 transfected. All reactions were tested in triplicate. Rat LHR mRNA expression was measured in the same way as in the miRNA assays.
Northern Blot Analysis
Primary rat granulosa cells were cultured in 60-mm dishes containing 1.5 3 10 5 viable cells in 5 ml of medium. After 24 h, the cells were incubated with FSH (30 ng/ml) and estradiol (10 nM) for 48 h and then transfected with PremiR-136-3p, Anti-miR-136-3p, or Pre-miR-negative control #1 (control [Cont] ). Twelve hours later, cells were treated with 30 ng/ml hCG. After another 12 h, the cultures were harvested using Isogen (Nippon Gene, Toyama, Japan). The final RNA pellet was dissolved in diethylpyrocarbonate-treated H 2 O. Total RNA was quantified by measuring the absorbance of samples at 260 nm. For Northern blot analysis, 10 lg of RNA from each dish was separated by electrophoresis on denaturing agarose gels and subsequently transferred to a nylon membrane (Biodyne; Pall Corp., Pensacola, FL). The detection and quantification of LHR mRNA expression were described previously [26] .
Binding Assay Using 125 I-hCG
The experimental design was same as that described in Northern blot analysis, except that the granulosa cells were used for the binding assay at 0, 12, 24, 48, and 72 h to measure the amount of LHR at the cell surface after the addition of hCG. A binding assay was performed by measuring the binding of a single, saturating concentration of 125 I-hCG to intact cells during a 1-h incubation at room temperature, as described previously [27] .
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Reporter Vectors and DNA Constructs
To identify the rno-miR-136-3p-binding site at the 3 0 end of LHR mRNA, we generated a direct-match miRNA target site and cloned the insert into the multiple cloning site in the luciferase reporter vector from the pMER-RE-PORT miRNA expression reporter vector system (Applied Biosystems). The miR-136-3p-binding site was predicted to be in the 3 0 -UTR of rat LHR mRNA according to the miRBase (described above). Inserts containing the LHR 3 0 -UTR were generated from rat genomic DNA as follows: (1) Luciferase (Luc) vector (wild type: WT), including the putative miR-136-3p-binding site 5 0 -GCATATTGTTTTCGATGAT-3 0 (the seed region is underlined); (2) Luc vector (mutation 1: Mut 1), a part of the seed region of the miR-136-3p-binding site was deleted, 5 0 -GCATATTGTTTTCGAT-3 0 ; (3) Luc vector (Mut 2), the seed region of the binding site was reversed, 5
0 -GCATATTGTTTTCTAG TAG-3 0 . The insert for (1) Luc vector (WT) was PCR-amplified from rat LHR genomic DNA by using the following flanking primers: forward primer 5 0 -AATGCACTAGTAGGAGG CACAGATGCAAACT-3 0 and reverse primer 5 0 -GCATTAAGCTTGGAG GAGGGCAAAATACAGA-3
0 . An SpeI site (underlined ACTAGT) was added to the forward primer at the 5 0 terminus, and a HindIII site (double underline AAGCTT) was added to the reverse primer at the 5 0 terminus. The inserts for (2) Luc vector (Mut 1) or (3) Luc vector (Mut 2) were generated by using the flanking primers (described above) and by following mutagenesis primers by overlap extension PCR: (2) Luc vector (Mut 1), forward primer 5 0 -GCATATTGTTTTCGATTACATGCTTTC-3 0 and reverse primer 5 0 -GAAAGCATGTAATCGAAAACAATATGC-3 0 ; (3) Luc vector (Mut 2), forward primer 5 0 -GCATATTGTTTTCTAGTAGTACATGCTTTC-3 0 and reverse primer 5 0 -GAAAGCATGTACTACTAGAAAACAATATGC-3 0 . PCR was performed using Taq DNA polymerase (Sigma), using standard PCR protocols. PCR products were resolved on 1% agarose gels stained with ethidium bromide. Gels containing the inserted cDNA (including or not including the miR-136-3p-binding site) were excised and eluted using the QIAquick gel extraction kit (Qiagen GmbH, Hilden, Germany). These inserts were digested with HindIII and SpeI and cloned into the HindIII and SpeI sites upstream of the luciferase gene in the pMER-RE-PORT miRNA expression reporter vector (Applied Biosystems). The sequences of the inserts were confirmed by sequence analysis using a Prism 3100 genetic analyzer (Applied Biosystems).
Luciferase Assay
First, we examined the b-galactosidase (b-gal) assay results to determine the efficiency of pMIR-RE-PORT b-gal vector expression using b-gal staining kit (Mirus, Madison, WI) according to the manufacturer's instructions. These results provided the experimental conditions described below.
Rat granulosa cells (8.0 3 10 4 to 10 3 10 4 cells) obtained from DES-primed rats were plated in 24-well plates and simultaneously treated with 30 ng/ml rat FSH and 10 nM estradiol. The cells were then transfected 36 h later with 200 ng of each vector (pMIR-RE-PORT luciferase vectors as described above and pMIR-RE-PORT b-gal vector as a control for transfection normalization) and 200 nM Anti-miR-136-3p (Ambion, Inc.) by using siPORT Neo-FX transfection agent according to the manufacturer's protocol. Twelve hours after transfection, 30 ng/ml hCG was added to induce down-regulation of LHR mRNA.
To measure the luciferase activity, we harvested the transfected cells and carried out the luciferase assay using the pMIR-RE-PORT miRNA expression reporter vector system (Applied Biosystems) at 12 h after hCG treatment.
Data Analysis
Microarray data were first filtered by subtracting the control probe data. To identify miRNAs that were differentially expressed, a one-way ANOVA test was performed among the four groups (hCG at 0 h, hCG at 6 h, hCG at 12 h, and hCG at 24 h). False discovery rates were assessed using the BenjaminiHochberg method. Hierarchical clustering was then performed by using the complete linkage method.
Comparisons among groups were performed using one-way ANOVA, followed by the Dunnett multiple comparison test. Data represent means 6 SE from at least three independent experiments. A p value of less than 0.05 was considered significant.
RESULTS
First, we used miRNA microarray analysis to identify miRNAs that were differentially expressed in rat ovaries following down-regulation of LHR mRNA by an ovulatory dose of hCG. Based on differentially expressed miRNAs, cluster analysis was executed to generate subgroups separated by expression patterns among the four groups (hCG at 0 h, hCG at 6 h, hCG at 12 h, and hCG at 24 h). A total of 44 miRNAs (Table 1) were found to differ significantly in response to hCG treatment, as measured using the BenjaminiHochberg method, suggesting that these miRNAs affected the down-regulation of LHR mRNA. From these 44 miRNAs, we chose to highlight 23 (Table 2) , which were increased at 6 h by hCG treatment and then decreased by 24 h. We were particularly interested in miR-136-3p because it can bind to the 3 0 -UTR of LHR mRNA (from bp 2848-2866) to negatively regulate LHR expression, based on the bioinformatics database, miRBase (http://www.mirbase.org/).
We previously demonstrated that LHR mRNA is downregulated during the pseudoestrous cycle in eCG-/hCG-treated rat ovaries [10] . Therefore, we measured the expression of LHR Consistent with previous studies [10, 28] , LHR mRNA was downregulated to its lowest level at 12 h after administration of an ovulatory dose of hCG (Fig. 1A) and was then increased at 24 h. In contrast to LHR mRNA, miR-136-3p expression reached a peak level at 6 h after hCG treatment, prior to the decrease in LHR mRNA levels (Fig. 1B) . Next, we investigated the effects of miR-136-3p on LHR mRNA expression in granulosa cells isolated from DES-treated immature rats. As was the case with the in vivo study (Fig. 1) , LHR mRNA was significantly decreased at 12 h after the addition of hCG into the culture medium and increased afterward ( Fig. 2A) . Meanwhile, miR-136-3p expression was clearly induced to its highest level at 6 h (Fig. 2B) . These results, along with the results of the in vivo study, indicated that the increase in miR-136-3p expression preceded the downregulation of LHR mRNA, and hCG induced this downregulation of LHR mRNA.
We then decided to examine the effects of miR-136-3p on LHR mRNA levels following transfection with either Pre-miR-136-3p or Pre-miR-136-5p in granulosa cells. Because miR-136-5p is a complementary strand of miR-136-3p, generated during the maturation of miR-136-3p, miR-136-5p was used to confirm the specific effects of miR-136-3p on LHR mRNA. In this experiment, granulosa cells were cultured as described previously, except that cells were transfected with Pre-miR-136-3p 12 h prior to addition of hCG. LHR mRNA was significantly decreased by miR-136-3p transfection 24 h after hCG treatment (Fig. 3A) . On the other hand, LHR mRNA was FIG. 1. Time courses of rat LHR mRNA and miR-136-3p expression in rat ovaries, induced by eCG and hCG. Female 21-day-old rats injected subcutaneously with 30 IU/rat eCG, followed by 20 IU/rat hCG 48 h later, were euthanized at the indicated times. The ovaries were removed, and total RNA was isolated. Rat LHR mRNA (A) and miR-136-3p (B) expression levels were measured using real-time RT-PCR as described in Materials and Methods. The amounts of LHR mRNA and miR-136-3p in the hCG 0-h group were set at 1. Data were normalized for 18S rRNA (for LHR mRNA) and 4.5S RNA (H) (for miR-136-3p) levels in each sample and are given as means 6 SE of three independent experiments in the bar graphs. *Significantly different from the control value (LHR mRNA at hCG 0 h), P , 0.05. **Significantly different from the control value (miR-136-3p at hCG 0 h), P , 0.05.
FIG. 2.
Rat LHR mRNA and miR-136-3p expression in primary rat granulosa cell culture induced by FSH and hCG. Primary rat granulosa cells were prepared, and the indicated reagents were added to the medium after 24 h of culture. Cells were then incubated with FSH (30 ng/ ml) and estradiol (10 nM) for 48 h. Subsequently, hCG (30 ng/ml) was added to the culture medium, as described in Materials and Methods. Total RNA was isolated, and rat LHR mRNA (A) and miR-136-3p (B) expression levels were measured using real-time RT-PCR as described in Materials and Methods. The amounts of LHR mRNA and miR-136-3p in the hCG 0-h group were set at 1. Data were normalized for 18S rRNA (for LHR) and 4.5S RNA (H) (for miR-136-3p) levels in each sample and are given as means 6 SE of three independent experiments in the bar graphs. *Significantly different from the control value (LHR mRNA at hCG 0 h), P , 0.05. **Significantly different from the control value (miR-136-3p at hCG 0 h), P , 0.05.
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FIG. 3. Effects of Pre-miR-136-3p
and Anti-miR-136-3p transfection on rat LHR mRNA expression in primary rat granulosa cells. Primary rat granulosa cells were prepared, and the indicated reagents were added to the medium after 24 h of culture. The cells were incubated with FSH (30 ng/ml) and estradiol (10 nM) for 48 h. Pre-miR-136-3p, Anti-miR-136-3p, Pre-miR-136-5p, or Pre-miR-negative control #1 was transfected into cells, and 30 ng/ml hCG was added 12 h later. The effects of Pre-miR-136-3p (A), Anti-miR-136-3p (B), and Pre-miR-136-5p (C) on expression of LHR mRNA were measured using real-time RT-PCR, as described in Materials and Methods. Expression of LHR mRNA at hCG 0 h in the control (Pre-miR-negative control #1) was set at 1. Each value represents the mean 6 SE of three independent experiments. *Significantly different from the control value, P , 0.05. D and E) The effects of Pre-miR-136-3p or Anti-miR-136-3p transfection on miR-136-3p levels were measured using real-time RT-PCR, as described in Materials and Methods. Expression of miR-136-3p at hCG 0 h in the control (Pre-miR-negative control #1) was set at 1. Each value represents the mean 6 SE of three independent experiments. *Significantly different from Pre-miR-negative control #1 value, P , 0.05. miRNA-136-3p REGULATES LHR mRNA EXPRESSION upregulated following transfection with Anti-miR-136-3p, an inhibitor of miR-136-3p (Fig. 3B) . To test whether LHR mRNA was subjected to regulation by miR-136-3p at the transcriptional level, we measured the expression of miR-136-3p in the context of Pre-miR-136-3p or Anti-miR-136-3p transfection in the same experiment (Figs. 3D and 3E) . The results showed that transfection with Pre-or Anti-miR-136-3p specifically affected miR-136-3p expression. Moreover, Northern blot analysis revealed that miR-136-3p negatively regulated the entire LHR mRNA transcript (Figs. 4A and 4B) . Furthermore, 125 I-hCG binding assays demonstrated that transfection with Pre-miR-136-3p significantly decreased LHR protein levels on the cell surface (Fig. 5A ), whereas transfection with Anti-miR-136-3p significantly enhanced the cell surface expression of LHR protein (Fig. 5B) .
To confirm the miR-136-3p binding site on LHR mRNA, we constructed a reporter vector that contained the 3 0 end of LHR mRNA (bp 2570-2895) in the 3 0 -UTR positioned downstream of the Renilla luciferase coding region (Fig. 6B) . Thus, endogenously expressed miR-136-3p in granulosa cells diminished luciferase activity due to base-pairing of miR-136-3p in the predicted miRNA-mRNA duplex. The luciferase activity in cells transfected with the reporter vector containing the miR-136-3p binding site was reduced by almost 40% at 12 h after hCG treatment (Fig. 6C) . In contrast, transfection with AntimiR-136-3p and the reporter vector attenuated the reduction in luciferase activity resulting from endogenous miR-136-3p.
To further verify the specificity of miR-136-3p binding to its predicted site, we generated two reporter vectors that were mutated in the miR-136-3p-binding site. Analysis of the luciferase activity in cells following transfection with these reporters confirmed that the 3 0 end of LHR mRNA from bp 2848-2866 in the 3 0 -UTR was essential for miR-136-3p binding (Fig. 6A ).
DISCUSSION
Once a follicle reaches the preantral stage, pituitary gonadotropins appear to regulate follicle development mainly through gonadotropin receptors, including both the FSH and LH receptors [29] . In addition, various locally produced growth factors take part in the modulation of LHR functions [4, [30] [31] [32] . As the follicle grows to become a mature antral follicle, the expression of LHR is increased. The preovulatory LH surge triggers ovulation and causes a transient desensitization of the LH response and down-regulation of LHR expression. Previous data from our laboratory demonstrated that LHR mRNA is up-regulated in response to FSH in both an in vivo [10] and in vitro study [33] and is downregulated by hCG treatment. Notably, Nair and Menon [11] and Wang and KITAHARA ET AL.
Menon [12] found that Mvk binds to LHR mRNA, resulting in a reduction of LHR mRNA levels by increasing the instability of the transcript [11, 12] . They also clarified the fact that the protein kinase A (PKA)-dependent extracellular signal-related kinase (ERK) signaling pathway, activated by LHR stimulation, controls Mvk protein levels, thereby down-regulating LHR mRNA [34] . However, the molecular processes responsible for the down-regulation of LHR mRNA have not yet been defined in detail. Furthermore, recent emerging evidence demonstrating that miRNAs, evolutionally conserved RNA molecules, regulate gene expression at the post-transcriptional level have led us to hypothesize that miRNAs are also involved in the regulation of LHR mRNA.
In this study, we first used an miRNA microarray to identify candidate miRNAs in ovaries from eCG-primed rats injected with an ovulatory dose of hCG. As expected, dynamic changes in miRNA expression were observed around the time that LHR mRNA was down-regulated. To date, more than 800 different miRNAs have been identified in the human genome. Initially, miRNAs were thought act as a post-transcriptional silencing mechanism, differentiating between targets based on the matching of base pairs with target mRNA. However, imprecise base-pairing between miRNAs and their target mRNAs increases the difficulty of predicting miRNA targets. These results, combined with computational analyses provided by miRBase, which indicate that several miRNAs bind to the 3 0 -UTR of LHR mRNA, led us to focus on miR-136-3p for further studies. Importantly, luciferase assays demonstrated that miR-136-3p bound to LHR mRNA via a target sequence in the 3 0 -UTR of this transcript.
Several studies have found that miRNAs are involved in many biological systems [17] [18] [19] [20] [21] [22] . In plants, miRNAs generally have very high complementarity with their target mRNAs and function mainly in the direct degradation of these target mRNAs [35] . On the other hand, in animals, miRNAs are thought to cause predominantly translational blockades [36] . Moreover, under some circumstances, miRNAs can actually enhance translation [37] . With respect to the imprecise parity of miR-136-3p to the 3 0 -UTR of LHR mRNA, miR-136-3p appeared to inhibit protein synthesis instead of cleavage and destruction of LHR mRNA. Nevertheless, transfection with miR-136-3p in rat cultured granulosa cells decreased LHR mRNA levels, demonstrating that miR-136-3p was biologically relevant in the destruction of its target mRNA. The function of miRNAs in animals was first described in the context of Lin-14 regulation [38] ; that study suggested that miRNA caused a reduction in Lin-14 protein levels without affecting Lin-14 mRNA levels. However, the data were obtained from RNase protection experiments, which do not use full-length, intact mRNAs. Consistent with a study by Bagga et al. [39] which demonstrated that Lin-14 mRNA levels were decreased in proportion to Lin-4 miRNA expression with imperfect baseparing between the miRNA and its target mRNA, Northern blot analyses of cells transfected with miR-136-3p revealed a reduction in the entire LHR transcript. These data were further supported by quantitative RT-PCR, which demonstrated a relative reduction in LHR mRNA expression in response to increased levels of miR-136-3p. Furthermore, in mammalian cells, partially complementary miRNAs have been reported to cause deadenylation of the target mRNA to accelerate the decay of the mRNA [40] . MiR-125, another critical miRNA, has been shown to function through both translational repression and RNA decay, which is not a consequence of inhibiting target protein synthesis in mouse embryonal carcinoma cells [41] . These findings are contradictory to the initial proposal that miRNAs in mammalian cells downregulate protein expression by inhibition of the translation of their target mRNAs. Thus, we believe that our results provide another example of the functional mechanisms of miRNAs, which are defined not only on the basis of complementarity between the miRNA and its target mRNA.
The mechanisms regulating miRNA transcription are still unclear, as little is known about the transcription and posttranscriptional processing of miRNA genes. Several studies have indicated that regulatory elements upstream of miRNA genes are probably essential to the transcriptional and posttranscriptional regulation of miRNAs; miRNA expression is under the control of common regulatory sequences [45] [46] [47] . According to bioinformatic databases, miR-136-3p is coded on chromosome 6 q 32 from bp 134,186,000 to 134,187,200. Analysis of the transcription factor binding sites ;1000 nucleotides upstream of the miR-136-3p gene revealed that SP-1/3, C/EBP, and AP-1, the intermediate promoter activities of which are induced by LH in granulosa cells [48] [49] [50] , are located in the region. Thus, our results demonstrating that treatment with hCG increased miR-136-3p both in vivo and in   FIG. 4 . Effects of miR-136-3p on LHR mRNA transcripts in granulosa cells. A) Primary rat granulosa cells were prepared, and the indicated reagents were added to the medium after 24 h of culture. The cells were incubated with FSH (30 ng/ml) and estradiol (10 nM) for 48 h. Pre-miR-136-3p, Anti-miR-136-3p, or Pre-miR-negative control #1 was transfected into cells, and 30 ng/ml hCG was added 12 h later. Cells were harvested at 12 h after addition of hCG, and LHR mRNA levels were quantified by Northern blot analysis. B) Levels of LHR mRNA (5.4 kb) were quantified by densitometric scanning. Expression of LHR mRNA in the control (Cont) was set at 1, and mRNA levels were expressed as a ratio of the control (Cont) value. Absorbance values obtained from this experiment and from the two other experiments were standardized in relation to the Cont and are given as the means 6 SE of three independent experiments. *Significantly different from the Cont value (Pre-miR-136-3p), P , 0.05. **Significantly different from the Cont value (Anti-miR-136-3p), P , 0.05.
miRNA-136-3p REGULATES LHR mRNA EXPRESSION vitro led us to speculate that LH/hCG activates LHR for transcriptional activation by using one of these transcription factors to control miR-136-3p expression.
As mentioned above, the exposure of LHR to a preovulatory LH surge or a pharmacological dose of hCG decreased LHR mRNA, followed by the down-regulation of cell surface LHR. This down-regulation of LHR mRNA is thought to proceed through a post-transcriptional mechanism due to increased degradation of LHR mRNA [51] . However, it is unclear whether miRNA or Mvk controls the post-transcriptional regulation of LHR mRNA. In human granulosa cells, the high concentration of cellular cholesterol decreases Mvk expression, negatively affecting Mvk-mediated down-regulation of LHR mRNA [52] . This indicates that the regulation of Mvk is subjected to control by cholesterol metabolism to some extent in granulosa cells. On the other hand, despite emerging evidence regarding pretranscriptional, transcriptional, and posttranscriptional regulation of miRNAs, the biogenetic mechanisms regulating miRNA expression have been wholly defined for only a few miRNAs. Thus, it is necessary to fully define the regulation of miR-136-3p expression for a better understanding of the post-transcriptional regulation of LHR mRNA.
In conclusion, we showed that induction of miR-136-3p by hCG destabilized LHR mRNA, resulting in the transient downregulation of LHR mRNA in granulosa cells after ovulation. Thus, our findings provide insight into the regulation of LHR mRNA expression in the ovaries. Although the precise mechanisms regulating miR136-3p have not been defined, our data suggested that the transcription factors located upstream of the miR-136-3p gene may be involved in the transcription of this critical miRNA.
FIG. 5. Effects of miR-136-3p
on LHR expression at the cell surface. Primary rat granulosa cells were prepared, and the indicated reagents were added to the medium after 24 h of culture. The cells were incubated with FSH (30 ng/ml) and estradiol (10 nM) for 48 h. Pre-miR-136-3p, Anti-miR-136-3p, or PremiR-negative control #1 was transfected into cells, and 30 ng/ml hCG was added 12 h later. The effects of Pre-miR-136-3p (A) and Anti-miR-136-3p (B) on the expression of cell surface LHR were evaluated by 125 I-hCG binding assays in granulosa cells as described in Materials and Methods. Each value represents the means 6 SE of three independent experiments. *Significantly different from the Pre-miR-negative control #1 value, P , 0.05.
